Adelita Tinoco1, David W Mortara2, Xiao Hu2, Cass Piper Sandoval3, Michele M Pelter2. 1. University of California San Francisco, School of Nursing, San Francisco, CA, USA. Electronic address: Adelita.Tinoco@gmail.com. 2. University of California San Francisco, School of Nursing, San Francisco, CA, USA. 3. University of California San Francisco Medical Center, San Francisco, CA, USA.
Abstract
BACKGROUND: Cheyne-Stokes respiration and periodic breathing (CSRPB) have not been studied sufficiently in the intensive care unit setting (ICU). OBJECTIVES: To determine whether CSRPB is associated with adverse outcomes in ICU patients. METHODS: The ICU group was divided into quartiles by CSRPB (86 patients in quartile 1 had the least CSRPB and 85 patients in quartile 4 had the most CSRPB). Adverse outcomes (emergent intubation, cardiorespiratory arrest, inpatient mortality and the composite of all) were compared between patients with most CSRPB (quartile 4) and those with least CSRPB (quartile 1). RESULTS: ICU patients in quartile 4 had a higher proportion of cardiorespiratory arrests (5% versus 0%, (p=.042), and more adverse events over all (19% versus 8%, p=.041) as compared to patients in quartile 1. CONCLUSIONS: CSRPB can be measured in the ICU and it's severity is associated with adverse outcomes in critically ill patients.
BACKGROUND: Cheyne-Stokes respiration and periodic breathing (CSRPB) have not been studied sufficiently in the intensive care unit setting (ICU). OBJECTIVES: To determine whether CSRPB is associated with adverse outcomes in ICU patients. METHODS: The ICU group was divided into quartiles by CSRPB (86 patients in quartile 1 had the least CSRPB and 85 patients in quartile 4 had the most CSRPB). Adverse outcomes (emergent intubation, cardiorespiratory arrest, inpatientmortality and the composite of all) were compared between patients with most CSRPB (quartile 4) and those with least CSRPB (quartile 1). RESULTS: ICU patients in quartile 4 hada higher proportion of cardiorespiratory arrests (5% versus 0%, (p=.042), and more adverse events over all (19% versus 8%, p=.041) as compared to patients in quartile 1. CONCLUSIONS: CSRPB can be measured in the ICU and it's severity is associated with adverse outcomes in critically illpatients.
Authors: Adelita Tinoco; Barbara J Drew; Xiao Hu; David Mortara; Bruce A Cooper; Michele M Pelter Journal: Ann Noninvasive Electrocardiol Date: 2017-06-15 Impact factor: 1.468
Authors: P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi Journal: Circulation Date: 1999-03-23 Impact factor: 29.690
Authors: Sandra Van den Broecke; Olivier Jobard; Gilles Montalescot; Marie Bruyneel; Vincent Ninane; Isabelle Arnulf; Thomas Similowski; Valérie Attali Journal: Sleep Med Date: 2014-08-26 Impact factor: 3.492